domingo, 27 de marzo de 2016



National Cancer Institute - Division of Cancer Control and Population Sciences

Epidemiology and Genomics Research Program

Cancer Genomics and Epidemiology Navigator

Helzlsouer KJ et. al. Summary of the round table discussion on strategies for cancer prevention: diet, food, additives, supplements, and drugs. Cancer Res 1994 Apr 1;54(7 Suppl):2044s-2051s.
Patient safety and the next generation of HPV DNA tests. Am J Clin Pathol 2011 Mar;135(3):481; author reply 482-3.
Kinney W et. al. Special commentary: patient safety and the next generation of HPV DNA tests. Am J Clin Pathol 2010 Aug;134(2):193-9.
Qian H et. al. The efficacy and safety of crizotinib in the treatment of anaplastic lymphoma kinase-positive non-small cell lung cancer: a meta-analysis of clinical trials. BMC Cancer 2014;14:683.
Rivera DR et. al. Pediatric exclusivity: evolving legislation and novel complexities within pediatric therapeutic development. Ann Pharmacother 2014 Mar;48(3):369-79.
Monami M et. al. Safety of dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized clinical trials. Curr Med Res Opin 2011 Nov;27 Suppl 3:57-64.
O'Bryant CL et. al. A dose-ranging study of the pharmacokinetics and pharmacodynamics of the selective apoptotic antineoplastic drug (SAAND), OSI-461, in patients with advanced cancer, in the fasted and fed state. Cancer Chemother Pharmacol 2009 Feb;63(3):477-89.
Huang M et. al. Metabolism of an Alkylated Polycyclic Aromatic Hydrocarbon 5-Methylchrysene in Human Hepatoma (HepG2) Cells. Chem Res Toxicol 2015 Oct 19;28(10):2045-58.
Jennison C et. al. Meta-analyses and adaptive group sequential designs in the clinical development process. J Biopharm Stat 2005;15(4):537-58.
Bode AM et. al. Signal transduction pathways: targets for chemoprevention of skin cancer. Lancet Oncol 2000 Nov;1:181-8.
Brown SL et. al. Silicone breast implants and autoimmune disease. J Am Med Womens Assoc 1998 Winter;53(1):21-4, 40.
Niraula S et. al. The price we pay for progress: a meta-analysis of harms of newly approved anticancer drugs. J Clin Oncol 2012 Aug 20;30(24):3012-9.
Bennett CL et. al. Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. JAMA 2008 Feb 27;299(8):914-24.
Sun J et. al. Meta-analysis of randomized controlled trials on laparoscopic gastrectomy vs. open gastrectomy for distal gastric cancer. Hepatogastroenterology 2012 Sep;59(118):1699-705.
Wimmerová S et. al. The spatial distribution of human exposure to PCBs around a former production site in Slovakia. Environ Sci Pollut Res Int 2015 Oct;22(19):14405-15.
Ibrahim JG et. al. Bayesian meta-experimental design: evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes. Biometrics 2012 Jun;68(2):578-86.
Chen MH et. al. Bayesian sequential meta-analysis design in evaluating cardiovascular risk in a new antidiabetic drug development program. Stat Med 2014 Apr 30;33(9):1600-18.
Schutz FA et. al. Meta-analysis of randomized controlled trials for the incidence and risk of treatment-related mortality in patients with cancer treated with vascular endothelial growth factor tyrosine kinase inhibitors. J Clin Oncol 2012 Mar 10;30(8):871-7.
Nguyen PL et. al. Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials. JAMA 2011 Dec 7;306(21):2359-66.
Qi WX et. al. Paclitaxel-based versus docetaxel-based regimens in metastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials. Curr Med Res Opin 2013 Feb;29(2):117-25.

No hay comentarios:

Publicar un comentario